Chronic cancer pain is a serious complication of malignancy or its treatment. Currently, no
comprehensive, universally accepted cancer pain classification system exists. Clarity in …

Background In the SPARTAN trial, addition of apalutamide to androgen deprivation therapy,
as compared with placebo plus androgen deprivation therapy, significantly improved …

Objectives To evaluate the evidence base for patient, oncological, and treatment prognostic
factors associated with multiple mental wellbeing outcomes in prostate cancer patients …

Background In the phase 3 TITAN study, the addition of apalutamide to androgen
deprivation therapy (ADT) significantly improved the primary endpoints of overall survival …

Objectives: The coronavirus disease 2019 (COVID-19) pandemic abruptly disrupted cancer
care. The impact of these disruptions on patient experiences remain relatively understudied …

Background There are uncertainties about prostate cancer‐related anxiety's (PCRA)
associations with health‐related quality of life (HRQOL) and major depression, and these …

Non-communicable diseases, including cancer, start to become more common in Indonesia.
According to the government statement, incidence of malignant diseases increased annually …

Background: Cancer patients frequently experience psychological problems related to
reactions of cancer diagnosis, cancer type, treatment effects, recurrence, fear of end-of-life …

Objectives. To estimate the prevalence of unsuspected anxiety or depression in prostate
cancer patients and their spouses, as well as factors involved in its onset. Materials and …

Relative to non-Hispanic whites (NHW), black men are disproportionately affected by
prostate cancer (PC) incidence, have poorer PC outcomes, and report greater compromises …